Author:
Curtis Jeffrey R.,Chen Lang,Danila Maria I.,Saag Kenneth G.,Parham Kathy L.,Cush John J.
Abstract
Objective.The aim of our study was to examine why real-world practices and attitudes regarding quantitative measurements of rheumatoid arthritis (RA) have received limited attention.Methods.An e-mail survey asked US rheumatologists to self-report on their use of quantitative measurements (metric).Results.Among 439 respondents, metric rheumatologists (58%) were more likely to be in group practice and to use tumor necrosis factor inhibitors. The quantitative tools most commonly used were the Health Assessment Questionnaire (35.5%) and the Routine Assessment of Patient Index Data 3 (27.1%). Reasons for not measuring included time needed and electronic availability. Based on simulated case scenarios, providing more quantitative information increased the likelihood that a patient would change to a different disease-modifying antirheumatic drug or biologic.Conclusion.Routine use of quantitative measurement for patients in the United States with RA is increasing over time but remains low.
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献